Annual report pursuant to Section 13 and 15(d)

Financial instruments - Collaboration and License Agreement (Details)

v3.20.4
Financial instruments - Collaboration and License Agreement (Details)
12 Months Ended
Dec. 31, 2020
USD ($)
customer
Collaboration and License Agreement  
Number of customers | customer 2
Trade receivables $ 139,000
Amounts past due 0
GlaxoSmithKline Intellectual Property Development Ltd | Astellas Collaboration Agreement  
Collaboration and License Agreement  
Impairment losses $ 0